Clinical trial
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NCT02862262 is registered in ClinicalTrials.gov with Luminex Molecular Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
- Lead sponsor
- Luminex Molecular Diagnostics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- November 14, 2016
- Enrollment
- 1,052 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
bordetella infections, bordetella parapertussis infection, bordetella pertussis infection